marketing analysis | brand planning | graphic design | medical illustration | copywriting
TRG Communications specializes in serving the marketing needs of emerging and mid-size pharmabio and diagnostic companies. Every drug, medical device and diagnostic test marketed in today’s cost-constrained environment confronts a core set of challenges. Overcoming these challenges requires the development and execution of fundamental and cost-effective commercial practices, which we can deliver.
TRG Communications allows your marketing budget go further without compromising strategic insight, creative execution or regulatory understanding. Our business model has proven to work, enabling many emerging companies to monetize the value of their brands. Several of our previous clients have realized their brand’s success either through commercial success or the purchase of their company. Some examples include TEAMM Pharmaceuticals (purchased by Accentia), Slate Pharmaceuticals (purchased by Actient and then Auxilium), PGxHealth (purchased by Transgenomic), Clinical Data (purchased by Forest Laboratories) and Arbor Pharmaceuticals (purchased by investment group, remains ArborPharmaceuticals).
Don’t hesitate to give us a call to discuss the challenges your brand is confronting
and how TRG Communications can partner with you for success.